Literature DB >> 20415903

Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.

A K Israni1, J J Snyder, M A Skeans, Y Peng, J R Maclean, E D Weinhandl, B L Kasiske.   

Abstract

Traditional risk factors do not adequately explain coronary heart disease (CHD) risk after kidney transplantation. We used a large, multicenter database to compare traditional and nontraditional CHD risk factors, and to develop risk-prediction equations for kidney transplant patients in standard clinical practice. We retrospectively assessed risk factors for CHD (acute myocardial infarction, coronary artery revascularization or sudden death) in 23,575 adult kidney transplant patients from 14 transplant centers worldwide. The CHD cumulative incidence was 3.1%, 5.2% and 7.6%, at 1, 3 and 5 years posttransplant, respectively. In separate Cox proportional hazards analyses of CHD in the first posttransplant year (predicted at time of transplant), and predicted within 3 years after a clinic visit occurring in posttransplant years 1-5, important risk factors included pretransplant diabetes, new onset posttransplant diabetes, prior pre- and posttransplant cardiovascular disease events, estimated glomerular filtration rate, delayed graft function, acute rejection, age, sex, race and duration of pretransplant end-stage kidney disease. The risk-prediction equations performed well, with the time-dependent c-statistic greater than 0.75. Traditional risk factors (e.g. hypertension, dyslipidemia and cigarette smoking) added little additional predictive value. Thus, transplant-related risk factors, particularly those linked to graft function, explain much of the variation in CHD after kidney transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20415903     DOI: 10.1111/j.1600-6143.2009.02949.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  52 in total

1.  Predictive Score for Posttransplantation Outcomes.

Authors:  Miklos Z Molnar; Danh V Nguyen; Yanjun Chen; Vanessa Ravel; Elani Streja; Mahesh Krishnan; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

2.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Troponin I levels and postoperative myocardial infarction following renal transplantation.

Authors:  G R Shroff; S K Akkina; M D Miedema; R Madlon-Kay; C A Herzog; B L Kasiske
Journal:  Am J Nephrol       Date:  2012-01-25       Impact factor: 3.754

4.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

Review 5.  Lipid abnormalities in kidney disease and management strategies.

Authors:  Vishwam Pandya; Akhilesh Rao; Kunal Chaudhary
Journal:  World J Nephrol       Date:  2015-02-06

6.  The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation.

Authors:  Ivar A Eide; Trond Jenssen; Anders Hartmann; Lien M Diep; Dag O Dahle; Anna V Reisæter; Kristian S Bjerve; Jeppe H Christensen; Erik B Schmidt; My Svensson
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-10       Impact factor: 8.237

7.  Impact of comorbidity on outcome in kidney transplant recipients: a retrospective study in Italy.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Paola Todeschini; Massimo Gallerani; Gaetano La Manna; Dimitri P Mikhailidis; Roberto Manfredini
Journal:  Intern Emerg Med       Date:  2016-03-22       Impact factor: 3.397

8.  Interferon-γ-mediated allograft rejection exacerbates cardiovascular disease of hyperlipidemic murine transplant recipients.

Authors:  Jing Zhou; Lingfeng Qin; Tai Yi; Rahmat Ali; Qingle Li; Yang Jiao; Guangxin Li; Zuzana Tobiasova; Yan Huang; Jiasheng Zhang; James J Yun; Mehran M Sadeghi; Frank J Giordano; Jordan S Pober; George Tellides
Journal:  Circ Res       Date:  2015-09-23       Impact factor: 17.367

9.  Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission: A Propensity Score Matched Cohort Study.

Authors:  Sergio A Acuna; Rinku Sutradhar; S Joseph Kim; Nancy N Baxter
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

10.  Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.